Justin Turner
Last active: 9/23/2020

Profile

Dr. Turner is an Associate Professor of Otolaryngology-Head and Neck Surgery at Vanderbilt University and Director of the Vanderbilt Smell and Taste Center. He completed his undergraduate education at Vanderbilt and received both his M.D. and Ph.D. degrees at the Medical University of South Carolina. He subsequently completed a residency in Otolaryngology-Head and Neck Surgery at the Johns Hopkins Hospital and a fellowship in Rhinology and Endoscopic Skull Base Surgery at Stanford University. Dr. Turner developed an active NIH-supported translational research program after joining the Vanderbilt faculty in 2012 with primary interests in the immunology of chronic rhinosinusitis and mechanisms of olfactory loss. His clinical practice is focused on management of inflammatory sinus disease and skull base neoplasms.

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Interim analysis of an open-label randomized controlled trial evaluating nasal irrigations in non-hospitalized patients with coronavirus disease 2019. Kimura KS, Freeman MH, Wessinger BC, Gupta V, Sheng Q, Huang LC, Von Wahlde K, Das SR, Chowdhury NI, Turner JH (2020) Int Forum Allergy Rhinol
    › Primary publication · 32914928 (PubMed)
  2. Olfactory training: what is the evidence? Turner JH (2020) Int Forum Allergy Rhinol
    › Primary publication · 32776673 (PubMed)
  3. Elevated mucus interleukin-17A levels are associated with increased prior sinus surgery for chronic rhinosinusitis. Chapurin N, Li P, Chandra RK, Turner JH, Chowdhury NI (2020) Int Forum Allergy Rhinol
    › Primary publication · 32702209 (PubMed)
  4. Baseline mucus cytokines predict 22-item Sino-Nasal Outcome Test results after endoscopic sinus surgery. Chowdhury NI, Li P, Chandra RK, Turner JH (2020) Int Forum Allergy Rhinol 10(1): 15-22
    › Primary publication · 31645085 (PubMed)
  5. Neutrophils are underrecognized contributors to inflammatory burden and quality of life in chronic rhinosinusitis. Succar EF, Li P, Ely KA, Chowdhury NI, Chandra RK, Turner JH (2020) Allergy 75(3): 713-716
    › Primary publication · 31583712 (PubMed)
  6. Longitudinal stability of chronic rhinosinusitis endotypes. Yancey KL, Li P, Huang LC, Sheng Q, Chandra RK, Chowdhury NI, Turner JH (2019) Clin Exp Allergy 49(12): 1637-1640
    › Primary publication · 31541576 (PubMed) · PMC6910924 (PubMed Central)
  7. Advanced age adversely affects chronic rhinosinusitis surgical outcomes. Yancey KL, Lowery AS, Chandra RK, Chowdhury NI, Turner JH (2019) Int Forum Allergy Rhinol 9(10): 1125-1134
    › Primary publication · 31454179 (PubMed) · PMC6773466 (PubMed Central)
  8. Investigating the correlation between mucus cytokine levels, inflammatory cell counts, and baseline quality-of-life measures in chronic rhinosinusitis. Chowdhury NI, Chandra RK, Li P, Ely K, Turner JH (2019) Int Forum Allergy Rhinol 9(5): 538-544
    › Primary publication · 30629853 (PubMed)
  9. Patterns of olfactory dysfunction in chronic rhinosinusitis identified by hierarchical cluster analysis and machine learning algorithms. Morse JC, Shilts MH, Ely KA, Li P, Sheng Q, Huang LC, Wannemuehler TJ, Chowdhury NI, Chandra RK, Das SR, Turner JH (2019) Int Forum Allergy Rhinol 9(3): 255-264
    › Primary publication · 30485725 (PubMed) · PMC6397071 (PubMed Central)
  10. Chronic rhinosinusitis in elderly patients is associated with an exaggerated neutrophilic proinflammatory response to pathogenic bacteria. Morse JC, Li P, Ely KA, Shilts MH, Wannemuehler TJ, Huang LC, Sheng Q, Chowdhury NI, Chandra RK, Das SR, Turner JH (2019) J Allergy Clin Immunol 143(3): 990-1002.e6
    › Primary publication · 30468775 (PubMed) · PMC6408962 (PubMed Central)
  11. Automated classification of osteomeatal complex inflammation on computed tomography using convolutional neural networks. Chowdhury NI, Smith TL, Chandra RK, Turner JH (2019) Int Forum Allergy Rhinol 9(1): 46-52
    › Primary publication · 30098123 (PubMed) · PMC6318014 (PubMed Central)
  12. Mucus T helper 2 biomarkers predict chronic rhinosinusitis disease severity and prior surgical intervention. Turner JH, Li P, Chandra RK (2018) Int Forum Allergy Rhinol 8(10): 1175-1183
    › Primary publication · 29883053 (PubMed) · PMC6168400 (PubMed Central)
  13. Identification of clinically relevant chronic rhinosinusitis endotypes using cluster analysis of mucus cytokines. Turner JH, Chandra RK, Li P, Bonnet K, Schlundt DG (2018) J Allergy Clin Immunol 141(5): 1895-1897.e7
    › Primary publication · 29452200 (PubMed) · PMC5938108 (PubMed Central)
  14. Olfactory and middle meatal cytokine levels correlate with olfactory function in chronic rhinosinusitis. Wu J, Chandra RK, Li P, Hull BP, Turner JH (2018) Laryngoscope 128(9): E304-E310
    › Primary publication · 29417576 (PubMed) · PMC6082743 (PubMed Central)
  15. Role of tissue eosinophils in chronic rhinosinusitis-associated olfactory loss. Hauser LJ, Chandra RK, Li P, Turner JH (2017) Int Forum Allergy Rhinol 7(10): 957-962
    › Primary publication · 28742240 (PubMed) · PMC5624838 (PubMed Central)
  16. Safety and tolerability of surfactant nasal irrigation. Turner JH, Wu J, Dorminy CA, Chandra RK (2017) Int Forum Allergy Rhinol 7(8): 809-812
    › Primary publication · 28558139 (PubMed)
  17. Outcomes of endoscopic repair of cerebrospinal fluid rhinorrhea without lumbar drains. Adams AS, Russell PT, Duncavage JA, Chandra RK, Turner JH (2016) Am J Rhinol Allergy 30(6): 424-429
    › Primary publication · 28124654 (PubMed)
  18. Updates in anterior skull base reconstruction. Zuniga MG, Turner JH, Chandra RK (2016) Curr Opin Otolaryngol Head Neck Surg 24(1): 75-82
    › Primary publication · 26735312 (PubMed)
  19. Endoscopic endonasal resection of a giant middle fossa epidermoid cyst. Best J, Schneider JS, Turner JH (2015) Allergy Rhinol (Providence) 6(3): 195-7
    › Primary publication · 26686213 (PubMed) · PMC5391490 (PubMed Central)
  20. Delayed presentation of traumatic cerebrospinal fluid rhinorrhea: Case report and literature review. Guyer RA, Turner JH (2015) Allergy Rhinol (Providence) 6(3): 188-90
    › Primary publication · 26686211 (PubMed) · PMC5391488 (PubMed Central)
  21. Impact of omalizumab therapy on medication requirements for chronic rhinosinusitis. Chandra RK, Clavenna M, Samuelson M, Tanner SB, Turner JH (2016) Int Forum Allergy Rhinol 6(5): 472-7
    › Primary publication · 26679299 (PubMed)
  22. Probiotics in prevention and treatment of allergic rhinitis. Turner JH, Adams AS, Zajac A (2015) Am J Rhinol Allergy 29(6): e224
    › Primary publication · 26637575 (PubMed)
  23. Efficacy of olfactory training in patients with olfactory loss: a systematic review and meta-analysis. Pekala K, Chandra RK, Turner JH (2016) Int Forum Allergy Rhinol 6(3): 299-307
    › Primary publication · 26624966 (PubMed) · PMC4783272 (PubMed Central)
  24. Proinflammatory mediators alter expression of nuclear factor kappa B-regulating deubiquitinases in sinonasal epithelial cells. Li P, Wang Y, Turner JH (2015) Int Forum Allergy Rhinol 5(7): 583-9
    › Primary publication · 25907801 (PubMed) · PMC4725707 (PubMed Central)
  25. A systematic review and meta-analysis of probiotics for the treatment of allergic rhinitis. Zajac AE, Adams AS, Turner JH (2015) Int Forum Allergy Rhinol 5(6): 524-32
    › Primary publication · 25899251 (PubMed) · PMC4725706 (PubMed Central)
  26. Treatment outcomes in acute invasive fungal rhinosinusitis. Zuniga MG, Turner JH (2014) Curr Opin Otolaryngol Head Neck Surg 22(3): 242-8
    › Primary publication · 24756031 (PubMed)
  27. Chronic rhinosinusitis without nasal polyps is associated with increased expression of trefoil factor family peptides. Li P, Turner JH (2014) Int Forum Allergy Rhinol 4(7): 571-6
    › Primary publication · 24733740 (PubMed)
  28. Survival outcomes in acute invasive fungal sinusitis: a systematic review and quantitative synthesis of published evidence. Turner JH, Soudry E, Nayak JV, Hwang PH (2013) Laryngoscope 123(5): 1112-8
    › Primary publication · 23300010 (PubMed)
  29. Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Turner JH, Reh DD (2012) Head Neck 34(6): 877-85
    › Primary publication · 22127982 (PubMed)
  30. Aggressive sinonasal natural killer/T-cell lymphoma with hemophagocytic lymphohistiocytosis. Turner JH, Loyo M, Lin SY (2012) Am J Otolaryngol 33(1): 188-91
    › Primary publication · 21764176 (PubMed)
  31. Tumor necrosis factor alpha inhibits olfactory regeneration in a transgenic model of chronic rhinosinusitis-associated olfactory loss. Turner JH, Liang KL, May L, Lane AP (2010) Am J Rhinol Allergy 24(5): 336-40
    › Primary publication · 21243089 (PubMed) · PMC3021182 (PubMed Central)
  32. Endoscopic-assisted, closed rhinoplasty approach for excision of nasoglabellar dermoid cysts. Turner JH, Tunkel DE, Boahene DK (2010) Laryngoscope 120(11): 2223-6
    › Primary publication · 20938952 (PubMed)
  33. Secretion of beta-HCG from squamous cell carcinomas of the head and neck. Turner JH, Ross H, Richmon J (2010) Otolaryngol Head Neck Surg 143(1): 169-70
    › Primary publication · 20620641 (PubMed)
  34. Reversible loss of neuronal marker protein expression in a transgenic mouse model for sinusitis-associated olfactory dysfunction. Turner JH, May L, Reed RR, Lane AP (2010) Am J Rhinol Allergy 24(3): 192-6
    › Primary publication · 20537285 (PubMed) · PMC3021955 (PubMed Central)
  35. Technical advances in rhinologic basic science research. Ramanathan M, Turner JH, Lane AP (2009) Otolaryngol Clin North Am 42(5): 867-81, x
    › Primary publication · 19909865 (PubMed) · PMC6137331 (PubMed Central)
  36. Serotonin 5-HT1A receptor stimulates c-Jun N-terminal kinase and induces apoptosis in Chinese hamster ovary fibroblasts. Turner JH, Garnovskaya MN, Raymond JR (2007) Biochim Biophys Acta 1773(3): 391-9
    › Primary publication · 17208318 (PubMed)
  37. Ca2+-calmodulin and janus kinase 2 are required for activation of sodium-proton exchange by the Gi-coupled 5-hydroxytryptamine 1a receptor. Turner JH, Garnovskaya MN, Coaxum SD, Vlasova TM, Yakutovich M, Lefler DM, Raymond JR (2007) J Pharmacol Exp Ther 320(1): 314-22
    › Primary publication · 17050776 (PubMed)
  38. Interaction of calmodulin with the serotonin 5-hydroxytryptamine2A receptor. A putative regulator of G protein coupling and receptor phosphorylation by protein kinase C. Turner JH, Raymond JR (2005) J Biol Chem 280(35): 30741-50
    › Primary publication · 15970592 (PubMed)
  39. G alpha 12/13- and reactive oxygen species-dependent activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase by angiotensin receptor stimulation in rat neonatal cardiomyocytes. Nishida M, Tanabe S, Maruyama Y, Mangmool S, Urayama K, Nagamatsu Y, Takagahara S, Turner JH, Kozasa T, Kobayashi H, Sato Y, Kawanishi T, Inoue R, Nagao T, Kurose H (2005) J Biol Chem 280(18): 18434-41
    › Primary publication · 15743761 (PubMed)
  40. Calmodulin interacts with the third intracellular loop of the serotonin 5-hydroxytryptamine1A receptor at two distinct sites: putative role in receptor phosphorylation by protein kinase C. Turner JH, Gelasco AK, Raymond JR (2004) J Biol Chem 279(17): 17027-37
    › Primary publication · 14752100 (PubMed)
  41. Mitogen-induced activation of Na+/H+ exchange in vascular smooth muscle cells involves janus kinase 2 and Ca2+/calmodulin. Garnovskaya MN, Mukhin YV, Turner JH, Vlasova TM, Ullian ME, Raymond JR (2003) Biochemistry 42(23): 7178-87
    › Primary publication · 12795614 (PubMed)
  42. Galpha(12/13) mediates alpha(1)-adrenergic receptor-induced cardiac hypertrophy. Maruyama Y, Nishida M, Sugimoto Y, Tanabe S, Turner JH, Kozasa T, Wada T, Nagao T, Kurose H (2002) Circ Res 91(10): 961-9
    › Primary publication · 12433842 (PubMed)